Searched for: in-biosketch:true
person:sum01
Biostatistics and Epidemiology Principles for the Toxicologist: The "Testy" Test Characteristics Part II: Positive Predictive Value and Negative Predictive Value
Williams, Christy; Sahagún, Barbara Elena; Su, Mark K
PMCID:10293502
PMID: 37314615
ISSN: 1937-6995
CID: 5538372
Medical Toxicology Education in Pediatrics Residency Training: Can It Be Improved? [Editorial]
Levene, Rachel; Renny, Madeline H; Seyoum, Theodros; Lim, Sungwoo; Fox, Carolyn; Su, Mark K
PMID: 37182661
ISSN: 1097-6833
CID: 5544062
Massive intentional enoxaparin overdose managed with minimal protamine: A single case report
de Olano, Jonathan; Howland, Mary Ann; Su, Mark K
DISCLAIMER/CONCLUSIONS:In an effort to expedite the publication of articles, AJHP is posting manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time. PURPOSE/OBJECTIVE:The case of a patient with a massive acute enoxaparin overdose managed with observation and minimal doses of protamine sulfate is reported. SUMMARY/CONCLUSIONS:Acute enoxaparin overdoses are uncommonly reported and management is widely variable. A 25-year-old man presented to the emergency department (ED) shortly after reporting that he had attempted suicide by injecting himself with 31 syringes of 80 mg of enoxaparin (a total of 2,480 mg) in the abdomen and other areas of his body. The patient also had self-inflicted superficial lacerations of the forearm. Due to concern over suspected compartment syndrome in the forearm, 25 mg of protamine was administered. Approximately 11 hours after reported enoxaparin self-injection, the patient's activated partial thromboplastin time (aPTT) was 206 seconds, prompting administration of an additional 50 mg of protamine. Three hours later, the aPTT had decreased to 79 seconds, then rose over several hours to 127 seconds before gradually declining to normal values. Protamine administration had no appreciable impact on anti-factor Xa activity. The patient did not require any blood products during the hospital admission. There were no further complications, and the patient was discharged to the inpatient psychiatry service on hospital day 8. CONCLUSION/CONCLUSIONS:The case highlights the role of protamine as a reversal agent in the management of low-molecular-weight heparin overdoses. The optimal dosing and efficacy of protamine for this indication needs further investigation.
PMID: 36786407
ISSN: 1535-2900
CID: 5432072
Response to "Do Higher Doses of Naloxone Increase the Risk of Pulmonary Complications?" [Comment]
Pires, Kyle D; Su, Mark K
PMID: 37002162
ISSN: 0736-4679
CID: 5463502
Correction to: Biostatistics and Epidemiology Principles for the Toxicologist: The "Testy" Test Characteristics Part I-Sensitivity and Specificity
Sahagún, Barbara Elena; Williams, Christy; Su, Mark K
PMID: 36542265
ISSN: 1937-6995
CID: 5394682
Retrospective evaluation of management guidelines for extracorporeal treatment of metformin poisoning
Trebach, Joshua; Mohan, Sanjay; Gnirke, Marlis; Su, Mark K; Gosselin, Sophie; Hoffman, Robert S
PMID: 36752699
ISSN: 1556-9519
CID: 5426912
Re: Cannabinoid hyperemesis syndrome: A 6-year audit of adult presentations to an urban district hospital [Letter]
Rothenberg, Roger; Selesny, Samantha; Su, Mark K
PMID: 36344260
ISSN: 1742-6723
CID: 5357102
Biostatistics and Epidemiology Principles for the Toxicologist: The "Testy" Test Characteristics Part I-Sensitivity and Specificity
Sahagún, Barbara Elena; Williams, Christy; Su, Mark K
PMID: 36422827
ISSN: 1937-6995
CID: 5384372
Early predictors of brain injury, acute CO poisoning, neuroprotection of mild hypothermia [Letter]
Wiener, Brian G; Su, Mark K; Hoffman, Robert S
PMID: 36283918
ISSN: 1532-8171
CID: 5359392
Neurologic and Thrombotic Complications in the Setting of Chronic Nitrous Oxide Abuse
Meier, E; Malviya, M; Kaur, S; Ibrahim, J; Corrigan, A; Moawad, A; Bukkuri, S A; Trebach, J; Su, M K; Pillai, M
Nitrous oxide is a commonly used inhaled anesthetic for medical procedures, as well as a drug of abuse throughout the world. Excessive nitrous oxide inhalation has been shown to cause a functional vitamin B12 deficiency and hyperhomocysteinemia, which can lead to peripheral neuropathy and hypercoagulability, respectively. While the development of neurologic toxicity from chronic nitrous oxide abuse (i.e., encephalopathy, myelopathy, and neuropathy) has been previously described, the thrombotic potential of chronic nitrous oxide abuse is less known. The authors report two cases of nitrous oxide abuse leading to both neurologic and thrombotic complications.
Copyright
EMBASE:2022338744
ISSN: 1687-9635
CID: 5510062